Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks
Ventilator Stocks Next Big Thing In Coronavirus-Hit Market?
By Zacks Investment ResearchStock MarketsMar 22, 2020 10:15PM ET
www.investing.com/analysis/ventilator-stocks-next-big-thing-in-coronavirushit-market-200518212
Ventilator Stocks Next Big Thing In Coronavirus-Hit Market?
By Zacks Investment Research | Mar 22, 2020 10:15PM ET The crippling impact of the coronavirus outbreak in the United States and worldwide has resulted in a wide shortage of treatment options. Hence, MedTech giants as well as non-healthcare stalwarts are collectively bracing up to sail through these difficult times in terms of bringing better healthcare devices and services to the patients. If the coronavirus-led market bloodbath has spooked you, then these are the stocks that might help enrich your portfolio, given the demand spike the companies are about to witness in the days to come.
Let’s delve deeper.
Ventilators — Key Equipment of the Hour
The number of critical-stage coronavirus patients has been soaring for quite some time now. In the United States alone, there are 795 patients, at present, in this stage. Internationally, the number of serious-to-critically ill coronavirus patients is nearing 11,000. If we take the Chinese data as standard, the mortality rate of this stage is 61.5% (study by The Lancet) and the key supportive treatment is mechanical ventilation, either invasively or non-invasively.
Recently, President Trump too urged the state governors to arrange for ventilators in order to meet the nationwide escalating demand. Going by a Fortune article, most ICUs currently have ventilators to meet demand of a regular flu season but do not have additional units in case of a demand surge. With the rapidly-spreading pandemic, experts are worried that such a situation might overwhelm hospitals, forcing doctors to implement triage systems, just like Italy is doing right now, to decide on who gets ventilation treatment.
In the wake of such difficult times, last week medical device stalwart Medtronic (NYSE:MDT) decided to more than double its capacity to manufacture and supply ventilators. Given the turbulence times, the company is also prioritizing high risk/high need areas for ventilator allocation on a weekly basis for efficient global distribution through supply chains. When all other major business segments of this Zacks Rank #3 (Hold) company are facing recessionary hurdles, Medtronic’s latest initiative seems strategic. This is anticipated to boost its Minimally Invasive Therapies Group revenues in the upcoming period.
Royal Philiips (NYSE:PHG) too has decided to ramp up manufacturing of its critical care products to meet the rising global demand. These products include patient vital signs monitors and portable ventilators, and medical consumables for non-invasive and invasive ventilation to treat a broad range of respiratory conditions. The company is particularly augmenting the production of hospital ventilators, and plans to double production within the next eight weeks and achieve a four-fold increase by third-quarter 2020. This Zacks Rank #3 stock will, undoubtedly, grab investors’ attention in the near term.
Koninklijke Philips N.V. Price
Koninklijke Philips N.V. Price
Koninklijke Philips N.V. price | Koninklijke Philips N.V. Quote
Another player in this field, which has been witnessing a significant demand spike for its devices, is ResMed (NYSE:RMD) . Despite the global supply disruption and the shut-down of its Singapore facility due to coronavirus outbreak, the company has conformed reallocation of resources away from producing other devices to meet the growing need of masks and ventilators (The Japan Times). The stock currently carries a Zacks Rank of #2 (Buy).
You can see the complete list of today’s Zacks #1 Rank stocks here.
Non-MedTechs Entering the Ventilators Space
Trump yesterday, in a tweet, announced that three major non-healthcare forces would be setting foot in the ventilator-manufacturing space. He stated that Ford Motor (NYSE:F) , General Motors (NYSE:GM) and Tesla (NASDAQ:TSLA) have already received the green light to make ventilators and other metal products. Per a Reuters’ report, Elon Musk said he had a discussion regarding ventilator production with Medtronic.
General Motors too has agreed to manufacture hospital ventilators. As per a Bloomberg report, the company’s CEO Mary Barra stated that General Motors might use some of its excess factory space to build ventilators.
We expect the above-mentioned non-MedTech bigwigs, all carrying a Zacks Rank #3 currently, to witness a surge over the next few months, if the respective deals materialize.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
See 5 Stocks Set to Double>>
Ford Motor Company (F): Free Stock Analysis Report
Koninklijke Philips N.V. (PHG): Free Stock Analysis Report
Medtronic PLC (MDT): Free Stock Analysis Report
General Motors Company (GM): Free Stock Analysis Report
ResMed Inc. (RMD): Free Stock Analysis Report
Tesla, Inc. (TSLA): Free Stock Analysis Report
Original post
Related Articles
Will Alibaba’s $53B AI Bet Be the Key to Tech Supremacy?
By Leo Miller - Feb 27, 2025
Shares of Alibaba (NYSE:BABA) are on a tear to start off 2025. The consumer discretionary and tech stock is up by 52% this year as of the Feb. 25 close. The company’s cloud...
2 Best AI-Driven CEP Stocks to Own in 2025
By Thomas Hughes - Feb 27, 2025
Every investor should know the term CEP, or customer engagement platform, because it is central to businesses' use of AI. CEPs provide software services to connect and communicate...
Sector Rotation Taking Hold as Healthcare Surges, Financials Lag
By James Picerno - Feb 27, 2025
As markets try to look through the blizzard of policy changes flowing out of Washington, the crowd has shifted its preferences considerably in recent weeks based on a sector lens....
Ventilator Stocks Next Big Thing In Coronavirus-Hit Market?
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.